Latest Neglected diseases Stories
Fight against river blindness is successful and inexpensive A relatively inexpensive program set up to combat river blindness, an infectious disease, has resulted in major health improvements in Africa, shows a study conducted by Erasmus University Medical Center researchers. The study, due to be published January 31 in PLOS Neglected Tropical Diseases, shows that US$250 million helped cure or prevent blindness, skin disease, severe itching, and other symptoms in millions of people. In...
NEW YORK, Jan. 16, 2013 /PRNewswire/ -- Global partners in the fight against neglected tropical diseases (NTDs) have made substantial progress over the past year, with more than 40 countries delivering detailed plans to control and eliminate these diseases and major pharmaceutical companies donating more than one billion treatments to meet 100 percent of drug requests by endemic countries. These successes are outlined in a new report, From Promises to Progress, released today in...
National Science Foundation Treatment for snail-borne schistosomiasis works best over the long haul Watch where you jump in for a swim or where your bath water comes from, especially if you live in Africa, Asia or South America. Snails that live in tropical freshwater in these locations are intermediaries between disease-causing parasitic worms and humans. People in developing countries who don't have access to clean water and good sanitation facilities are often exposed to the...
Tokyo, Oct 25, 2012 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has signed a global agreement with Brazil's Fundacao Oswaldo Cruz ("Fiocruz") aimed at collaborations to develop new medicines and vaccines for malaria and neglected tropical diseases (NTDs). Under the global agreement, Eisai and Fiocruz will identify research development collaborations targeting Eisai compounds for indications of malaria and NTDs. For the first collaboration, it has...
Phase IIb Proof of Concept Trial Planned for Kenya, India and South Africa ROCKVILLE, Md., Oct. 10, 2012 /PRNewswire-USNewswire/ -- Aeras announces that it has signed an agreement with GlaxoSmithKline Vaccines, S.A. (GSK) to jointly advance the clinical development of an investigational tuberculosis (TB) vaccine containing GSK's proprietary M72 antigen and AS01(E)(*) adjuvant. This novel research and resource-sharing agreement between the largest non-profit TB vaccine biotech and...
Successful Public-Private Partnerships Hope to Encourage Increased Private and Public Sector Participation BERLIN, Sept. 28, 2012 /PRNewswire-USNewswire/ -- Global health advocates and the pharmaceutical industry came together to discuss strategies for improved collaboration and increased private sector involvement in neglected tropical disease (NTD) treatment and control programs. During a workshop in Berlin, experts from the World Health Organization (WHO), the Bill & Melinda...
Shipment from Health Partners International of Canada will save lives of people affected by disease which has struck nearly 20,000 MONTREAL, Sept. 25, 2012 /CNW/ - A large donation of a vitally needed treatment for cholera is on its way from the Montreal pharmaceutical company Pharmascience Inc. to the African country of Sierra Leone to treat people there who have been stricken by cholera in a serious outbreak of the disease which started earlier this year. The donation has...
STAMFORD, Conn., Sept. 13, 2012 /PRNewswire-USNewswire/ -- An emergency shipment of medical aid has arrived in Sierra Leone for the cholera epidemic that has already sickened 17,000 people and left more than 250 dead. The shipment contains enough oral rehydration solution, intravenous fluids, antibiotics, syringes, and other medical supplies to treat up to 15,000 patients at Ministry of Health and Sanitation cholera treatment centers in six districts. AmeriCares is also equipping...
Tokyo, Sept 12, 2012 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into a partnership agreement to supply the Sabin Vaccine Institute (Headquarters: Washington D.C., President: Dr. Peter Hotez, "Sabin") with E6020, an in-house developed adjuvant that enhances the immune effects of vaccines, as well as all relevant information pertaining to the compound free of charge, to support the development of vaccines for two neglected tropical...
Scientists at the University of Liverpool have found that the worm which causes River Blindness survives by using a bacterium to provide energy, as well as help 'trick' the body's immune system into thinking it is fighting a different kind of infection. River Blindness affects 37 million people, mainly in sub-Saharan Africa, causing intense itching of the skin, visual impairment and in severe cases, irreversible blindness. It is caused by a parasitic worm that is transmitted by...
Latest Neglected diseases Reference Libraries
The giant roundworm (Ascaris lumbricoides) is a parasitic worm within the Nematoda phylum. This species can be found throughout the world, but occurs in higher numbers in tropical and subtropical areas. It causes the disease known as ascariasis in its human hosts and infects about one quarter of the entire world’s human population. It displays a sexual dimorphism, with females growing larger than males. Females reach an average body length between 7.8 and 19.2 inches, while males reach a...
Wuchereria bancrofti is a species of roundworm in the Nematoda phylum. This species is spread through a mosquito vector, which means that it is transferred through mosquitos. This species infects over 120 million people in South America, Africa, and other tropical and subtropical areas. It is one of three species of parasitic worm that can cause lymphatic filariasis, which can lead to elephantiasis. The disease is wrongfully named, because the term translates to “a disease caused by...
Wuchereria bancrofti is a species of roundworm in the Nematoda phylum. This species is spread through a mosquito vector, which means that it is transferred through mosquitos. This species infects over 120 million people in South America, Africa, and other tropical and subtropical areas. It is one of three species of parasitic worm that can cause lymphatic filariasis, which can lead to elephantiasis. The disease is wrongfully named, because the term translates to “a disease caused by...
Yellow fever is an acute viral hemorrhagic disease with a 40 to 50 nm enveloped RNA virus with positive sense of the Flaviviridae family. It is transmitted by the bite of female mosquitoes and is found in tropical and subtropical areas in South America and Africa, but not in Asia. Primates and a few kinds of mosquitoes are the only known hosts. The origin of the disease is most likely Africa. From there it was introduced to South America through the slave trade in the 16th century. There...
Dengue fever and dengue hemorrhagic fever (DHF), caused by the dengue virus, is among the spectrum of acute febrile tropical disease and is transmitted by mosquitoes. Occurring mainly in the tropics it can be life threatening and is caused by four closely related virus stereotypes of the genus Flavivirus. It was identified and named in 1779. It has a nickname of "breakbone fever" due to it causing sever generalized bodyache. It tends to be more prevalent in the urban districts of its range...
